• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX PRO TORIC TRIFOCAL UV ABSORBING IOL; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX PRO TORIC TRIFOCAL UV ABSORBING IOL; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number PXCWT3
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Capsular Bag Tear (2639)
Date of Event 10/14/2025
Type of Reportable Event Serious Injury
Event or Problem Description
A non-health care professional reported that following an intraocular lens (iol) implant procedure, a posterior capsule tear had led to a decentered multifocal iol.It was also stated that the haptic or iol edge had torn the capsule posteriorly.The procedure was not completed the same day.Additional information has been requested.
 
Additional Manufacturer Narrative
A product was not returned for analysis.Complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.The manufacturer internal reference number is: (b)(4).
 
Additional Manufacturer Narrative
The product was returned for analysis.The reported complaint cannot be confirmed from the returned sample.Iol (intraocular lens) returned wrapped in surgical material inside a plastic bag.Solution is dried on the iol.The optic is torn/split-cut dividing the iol in two.There are fibers on the iol.The root cause for the reported complaint could not be determined.Based on the results from the product history record, the products met release criteria.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON PANOPTIX PRO TORIC TRIFOCAL UV ABSORBING IOL
Common Device Name
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key23790901
Report Number9612169-2025-02502
Device Sequence Number14881115
Product Code MJP
UDI-Device Identifier00380658433901
UDI-Public(01)00380658433901(17)290711(11)240713(10)25887669
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2025
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 03/16/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberPXCWT3
Device Catalogue NumberPXCWT3.165
Device Lot Number25887669
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/18/2025
Supplement Date Received by Manufacturer02/20/2026
Initial Report FDA Received Date12/12/2025
Supplement Report FDA Received Date03/16/2026
Date Device Manufactured07/13/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AMVISC PLUS.; CLAREON MONARCH IV IOL, INJECTOR.; MONARCH II LOADING FORCEPS.; MONARCH III IOL, CARTRIDGE D.
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient Age70 YR
Patient SexFemale
-
-